Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX® (daratumumab) for the Treatment of Patients with Multiple Myeloma

by NASDAQ Market News June 4, 2020

NASDAQ Market News
Click here to email author

Global Lateral Testing Market is Estimated to be USD 7.9 Billion by 2029 with a CAGR of 4.3% During the Forecast Period

Depression Screening Market Business Growth Analysis with Top Players: Vertical Pharmaceuticals, LLC, ACADIA Pharmaceuticals Inc., Medtronic, Meiji Holdings Company, Ltd., Bristol-Myers Squibb Company Considering COVID-19 Impact

Ads